{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:07:12Z","timestamp":1787022432315,"version":"build-2736575974"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Lung biopsy (LBx) has a relevant role in the prediction of prognosis of interstitial lung diseases (ILDs), but its impact on the clinical management of patients remains unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study evaluates whether LBx may change the therapeutic strategy and assesses the effect of diagnostic reclassification after LBx on long-term prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated the LBx of 426 consecutive patients with ILDs, without a definite usual interstitial pneumonia pattern on high-resolution computed tomographic imaging. A total of 266 patients underwent transbronchial lung cryobiopsy (TBLC), and 160 patients underwent surgical lung biopsy (SLB). The multidisciplinary team (MDT) determined a diagnosis with high or low confidence, and a management strategy, both before and after the LBx data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Final MDT diagnoses were 189 idiopathic pulmonary fibrosis (IPF), 143 non-IPF fibrotic ILDs, and 94 nonfibrotic ILDs. LBx data changed the management strategy in 145 cases (34%), with similar results for TBLC and SLB (the treatment strategy changed in 31.5% of TBLC cases, 84\/266, P\u2009&amp;lt;\u20090.001, and in 38% of SLB, 61\/160, P\u2009&amp;lt;\u20090.001). After LBx, the MDT was less inclined to \u201cwait and see\u201d (from 15% to 4% of cases, P\u2009&amp;lt;\u20090.001) or to prescribe steroids only (from 54% to 37%, P\u2009&amp;lt;\u20090.001) and was more confident to treat with antifibrotics (from 23% to 44%, P\u2009&amp;lt;\u20090.001) or immunosuppressive drugs (from 7% to 14%, P\u2009&amp;lt;\u20090.001). The therapeutic strategy changed in 70% of reclassified cases (60\/85) and in 59% of cases in which LBx increased the MDT confidence (84\/142). Reclassification significantly impacted the outcome. The cases classified as non-IPF by clinician and radiologist and then reclassified to be IPF after LBx showed a significantly worse survival compared with non-IPF confirmed cases (adjusted hazard ratio [HR], 3.8; 95% confidence interval [CI], 1.75\u20138.3); P\u2009=\u20090.001. Cases initially classified as IPF and then reclassified as non-IPF after LBx showed a better prognosis compared with IPF confirmed cases (HR, 0.41; 95% CI, 0.18\u20130.94; P\u2009=\u20090.03).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Reclassification of cases with LBx data increased diagnostic confidence and changed the therapeutic strategy in one-third of cases. Pathologic reclassification of cases refined prognosis prediction. Patients classified as non-IPF by clinician and radiologist and then reclassified IPF after LBx had worse prognosis compared with the non-IPF confirmed cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202104-466oc","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T15:23:24Z","timestamp":1636125804000},"page":"737-745","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":30,"title":["Impact of Lung Biopsy Information on Treatment Strategy of Patients with Interstitial Lung Diseases"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4781-6539","authenticated-orcid":false,"given":"Sara","family":"Tomassetti","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ravaglia","sequence":"additional","affiliation":[{"name":"Department of Diseases of the Thorax"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Puglisi","sequence":"additional","affiliation":[{"name":"Department of Diseases of the Thorax"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Ryu","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas V.","family":"Colby","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cavazza","sequence":"additional","affiliation":[{"name":"Dipartimento di Anatomia Patologica, Azienda Unit\u00e0 Sanitaria Locale\/Istituto di Ricovero e Cura a Carattere Scientifico di Reggio Emilia, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athol U.","family":"Wells","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Unit, Pulmonary Medicine, Royal Brompton Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Pavone","sequence":"additional","affiliation":[{"name":"Centro di Riferimento Regionale per le Malattie rare Polmonari, Azienda Ospedaliero Universitaria Policlinico \u201cG. Rodolico\u2013San Marco,\u201d Dipartimento di Medicina Sperimentale e Clinica, Universit\u00e0 di Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Vancheri","sequence":"additional","affiliation":[{"name":"Centro di Riferimento Regionale per le Malattie rare Polmonari, Azienda Ospedaliero Universitaria Policlinico \u201cG. Rodolico\u2013San Marco,\u201d Dipartimento di Medicina Sperimentale e Clinica, Universit\u00e0 di Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Lavorini","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Rosi","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Luzzi","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Gori","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Rossi","sequence":"additional","affiliation":[{"name":"Pathologic Anatomy, Azienda AUSL Romagna, Ravenna, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Donati","sequence":"additional","affiliation":[{"name":"Department of Diseases of the Thorax"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Dubini","sequence":"additional","affiliation":[{"name":"Human Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6608-0574","authenticated-orcid":false,"given":"Sara","family":"Piciucchi","sequence":"additional","affiliation":[{"name":"Radiology, G. B. Morgagni Hospital, Forl\u00ec, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venerino","family":"Poletti","sequence":"additional","affiliation":[{"name":"Department of Diseases of the Thorax"},{"name":"Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,1]]},"reference":[{"key":"2026012203315326700_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203315326700_bib2","doi-asserted-by":"crossref","first-page":"1800692","DOI":"10.1183\/13993003.00692-2018","article-title":"What\u2019s in a name? That which we call IPF, by any other name would act the same","volume":"51","author":"Wells","year":"2018","journal-title":"Eur Respir J"},{"key":"2026012203315326700_bib3","first-page":"1596","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease. Reply","volume":"381","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"2026012203315326700_bib4","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"2026012203315326700_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","article-title":"Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"8","author":"Maher","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026012203315326700_bib6","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012203315326700_bib7","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012203315326700_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/thoraxjnl-2017-210035","article-title":"Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis","volume":"73","author":"Gimenez","year":"2018","journal-title":"Thorax"},{"key":"2026012203315326700_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0036-1583176","article-title":"Nonspecific interstitial pneumonia: what is the optimal approach to management?","volume":"37","author":"Tomassetti","year":"2016","journal-title":"Semin Respir Crit Care Med"},{"key":"2026012203315326700_bib10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1164\/rccm.201104-0668OC","article-title":"Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study","volume":"184","author":"Lamas","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203315326700_bib11","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Raghu","year":"2012","journal-title":"N Engl J Med"},{"key":"2026012203315326700_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/ajrccm.157.1.9704130","article-title":"Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis","volume":"157","author":"Bjoraker","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203315326700_bib13","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.chest.2019.10.048","article-title":"transbronchial cryobiopsy for the diagnosis of interstitial lung diseases: CHEST guideline and expert panel report","volume":"157","author":"Maldonado","year":"2020","journal-title":"Chest"},{"key":"2026012203315326700_bib14","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S2213-2600(20)30122-3","article-title":"Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: a retrospective validation study","volume":"8","author":"Tomassetti","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026012203315326700_bib15","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203315326700_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2213-2600(19)30342-X","article-title":"Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study","volume":"8","author":"Troy","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026012203315326700_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12890-019-0780-3","article-title":"Diagnostic yield and risk\/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients","volume":"19","author":"Ravaglia","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2026012203315326700_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12890-021-01438-1","article-title":"Implementation of transbronchial lung cryobiopsy in a tertiary referral center for interstitial lung diseases: a cohort study on diagnostic yield, complications, and learning curves","volume":"21","author":"Davidsen","year":"2021","journal-title":"BMC Pulm Med"},{"key":"2026012203315326700_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/LBR.0000000000000716","article-title":"Transbronchial cryobiopsy in interstitial lung diseases: state-of-the-art review for the interventional pulmonologist","volume":"28","author":"Avasarala","year":"2021","journal-title":"J Bronchology Interv Pulmonol"},{"key":"2026012203315326700_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12931-021-01821-w","article-title":"Integration of transbronchial cryobiopsy into multidisciplinary board decision: a single center analysis of one hundred consecutive patients with interstitial lung disease","volume":"22","author":"Hostettler","year":"2021","journal-title":"Respir Res"},{"key":"2026012203315326700_bib21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4081\/mrm.2021.731","article-title":"Feasibility, utility, and safety of transbronchial cryobiopsy for interstitial lung diseases in Japan","volume":"16","author":"Ikeda","year":"2021","journal-title":"Multidiscip Respir Med"},{"key":"2026012203315326700_bib22","article-title":"A pilot study on the use of the super dimension navigation system for optimal cryobiopsy location in interstitial lung disease diagnostics","author":"Kronborg-White","year":"2021","journal-title":"Pulmonology"},{"key":"2026012203315326700_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5603\/ARM.2020.0086","article-title":"Transbronchial lung cryobiopsy guided by radial mini-probe endobronchial ultrasound in interstitial lung diseases - a multicenter prospective study","volume":"88","author":"Gnass","year":"2020","journal-title":"Adv Respir Med"},{"key":"2026012203315326700_bib24","doi-asserted-by":"crossref","first-page":"2000724","DOI":"10.1183\/13993003.00724-2020","article-title":"Safety and diagnostic efficacy of cone beam computed tomography-guided transbronchial cryobiopsy for interstitial lung disease: a cohort study","volume":"56","author":"Zhou","year":"2020","journal-title":"Eur Respir J"},{"key":"2026012203315326700_bib25","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1007\/s10067-021-05671-1","article-title":"Transbronchial lung cryobiopsy for connective tissue disease-related interstitial lung disease and interstitial pneumonia with autoimmune features: a single center retrospective case series","volume":"40","author":"Wu","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2026012203315326700_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MCP.0000000000000810","article-title":"Biopsy in interstitial lung disease: specific diagnosis and the identification of the progressive fibrotic phenotype","volume":"27","author":"Ravaglia","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"2026012203315326700_bib27","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1164\/rccm.201903-0493OC","article-title":"Diagnostic likelihood thresholds that define a working diagnosis of idiopathic pulmonary fibrosis","volume":"200","author":"Walsh","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203315326700_bib28","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.chest.2018.03.026","article-title":"Diagnostic ability of a dynamic multidisciplinary discussion in interstitial lung diseases: a retrospective observational study of 938 cases","volume":"153","author":"De Sadeleer","year":"2018","journal-title":"Chest"},{"key":"2026012203315326700_bib29","doi-asserted-by":"crossref","first-page":"102447","DOI":"10.1016\/j.autrev.2019.102447","article-title":"Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sj\u04e7gren\u2019s syndrome: a systematic review from the Italian Society of Rheumatology","volume":"19","author":"Sambataro","year":"2020","journal-title":"Autoimmun Rev"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/19\/5\/737\/66344357\/annalsats_19_5_737.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/19\/5\/737\/66344357\/annalsats_19_5_737.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:34:38Z","timestamp":1769070878000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/19\/5\/737\/8418976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,1]]},"published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202104-466oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5]]},"published":{"date-parts":[[2022,5,1]]},"assertion":[{"value":"2021-04-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}